Busulfan (IV Busulfex) is indicated for use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education